Heather Greene, NP, discusses the safety profile for patients with lung cancer receiving immunotherapy, and the importance for reporting immune-related adverse events.
Original Article: Guidelines Release Perspective on Managing Safety Profile of Immunotherapy in Lung Cancer
NEXT ARTICLE